CXCL10 participates in monocyte, neutrophil, and lymphocyte recruitment and significantly contributes to the progression of COPD disease state, which may present as a therapeutic target of AT-RvD1 in dust-induced lung disease (21, 75, 76). Here, CXCL10 is linked to lung disorder.